Aviron LLC clinical trials
Acquired by AstraZeneca, Jun 1, 2007 · source ↗
The registry lists 1 studies whose lead sponsor is Aviron LLC. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 26, 2020.
- 1study on the registry
- 0open to participants now
Before and after it joined AstraZeneca
- First submitted before Aviron LLC became part of AstraZeneca
- 0
- First submitted after Aviron LLC became part of AstraZeneca
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Aviron LLC’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Status unknown or other1100%
Where
- Russian Federation1
Over the years
- 120
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Aviron LLC1 study
Something wrong with this grouping? Tell us on the AstraZeneca page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All AstraZeneca studies →
- An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19Status unknownNCT04527133Not applicable
Sponsor listed in the registry: Aviron LLC · First submitted after Aviron LLC became part of AstraZeneca